Simulations Plus (NASDAQ: SLP) net income
Simulations Plus reported a net loss of $64.7m for fiscal 2025; in fiscal 2024 it reported a net profit of $10.0m. Earnings per share were −$3.22.
Simulations Plus's net income has fallen for 3 years in a row, and its best year of the last 10 was fiscal 2022. The biggest drop was in fiscal 2023, −20.2%. It reported a loss in 1 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$64.7m | −750.2% | −81.7% | −$3.22 |
| 2024 | $10.0m | −0.1% | 14.2% | $0.50 |
| 2023 | $10.0m | −20.2% | 16.7% | $0.50 |
| 2022 | $12.5m | +27.6% | 23.2% | $0.62 |
| 2021 | $9.8m | +4.8% | 21.1% | $0.49 |
| 2020 | $9.3m | +8.7% | 22.4% | $0.52 |
| 2019 | $8.6m | −3.9% | 25.3% | $0.49 |
| 2018 | $8.9m | +54.4% | 30.1% | $0.52 |
| 2017 | $5.8m | +16.9% | 24.0% | $0.34 |
| 2016 | $5.0m | — | 24.8% | $0.29 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Simulations Plus net income compared with its sector
By net income for its latest fiscal year, Simulations Plus ranks 282nd of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Simulations Plus, −81.7%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 280th | Alto Neuroscience | −$63.2m | — |
| 281st | Lineage Cell Therapeutics | −$63.5m | −436.5% |
| 282nd | Simulations Plus | −$64.7m | −81.7% |
| 283rd | Omniab | −$64.8m | −347.0% |
| 284th | Aclaris Therapeutics | −$64.9m | −829.6% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Simulations Plus
- How much did Simulations Plus earn in fiscal 2025?
- Simulations Plus reported a net loss of $64.7m for fiscal 2025. In fiscal 2024 it reported a net profit of $10.0m.
- What are the earnings per share of Simulations Plus?
- They were −$3.22 in fiscal 2025, compared with $0.50 in fiscal 2024.
- What was the most profitable year for Simulations Plus?
- Of its last 10 fiscal years, fiscal 2022, with $12.5m.
- Where does Simulations Plus rank in its sector by net income?
- It ranks 282nd of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Simulations Plus come from?
- From the annual report (Form 10-K) that Simulations Plus files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Simulations Plus files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Simulations Plus: the Simulations Plus page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.